Home >
News >
CALL FOR ABSTRACTS: 6th ESH Translational Research Conference LYMPHOID MALIGNANCIES
CALL FOR ABSTRACTS: 6th ESH Translational Research Conference LYMPHOID MALIGNANCIES
June 01, 2021
6th ESH Translational Research
Conference
LYMPHOID MALIGNANCIES
Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt
October 14-17 - E-Conference
CALL FOR ABSTRACTS
for oral or poster presentations!
DEADLINE: JULY 15, 2021
ABOUT THE CONFERENCE
In view of continuing COVID-19 related challenges, the 6th ESH Translational Research Conference on LYMPHOID MALIGNANCIES will be held as a virtual event.
REGISTRATION IS OFFERED FREE OF CHARGE as a gesture of solidarity during these difficult times.
About the programme:
This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.
The goals of this conference are to:
– foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide.
– foster scientific cross-fertilization between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment.
– provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training
A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of Lymphoid Malignancies.
Learning objectives:
Improved understanding of :
– current developments in the field of molecular pathogenesis of indolent and aggressive B-cell lymphoma including CLL
– current developments in the field of the molecular pathogenesis of T-cell lymphoma
– prognostic and predictive markers and their impact in specific clinical situations
– current treatments and future therapeutic perspectives.
SCIENTIFIC TOPICS:
– B-cell development and lymphomagenesis
– Genetics of malignant lymphomas and clonal evolution
– Epigenetics in malignant lymphomas
– Deregulated proteome and metabolome
– Single cell analyses, circulating tumor DNA, MRD
– Oncogenic signaling pathways
– Utilizing oncogenic signaling therapeutically
– Immunologic approaches in the treatment of lymphomas
STAY TUNED
REGISTRATION OPENING SOON
TO ACCESS THE PROGRAMME CLICK HERE
MORE INFORMATION
With the support of*:
Premium E-Conference Partners
*******
Diamond E-Conference Partners
*******
Emerald E-Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.